I recently had the pleasure to spend time with the team at Applied Clinical Trials. Following our discussion they published an interview in the September edition of Applied Clinical Trials Magazine.
The interview is titled “Workforce Readiness Technology Minimizes Risk in Clinical Trials” and it explores how ArcheMedX is enabling Sponsors, CROs, and other trial stakeholders to improve clinical trial readiness.
Here’s the introduction and the full interview can be found below. Enjoy!
“Clinical trials often encounter operational challenges and sponsors and CROs seek effective site-readiness practices. In this interview, Joel B. Selzer, co-founder and CEO, ArcheMedX, Inc., discusses the impact that healthcare technology has on clinical trials, focusing on the development of the company’s workforce readiness platform.”
Related Post
ArcheMedX Celebrates Key Milestones for Ready Platform Since DIA Launch
Ready has powered 1,000,000 user sessions with clinical professionals in over 90 countries to become…
ArcheMedX Team
Battling ‘Sludge’ in Clinical Trials: A Call to Action
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and…
Brian S McGowan, PhD
Breaking the Cycle of Ineffective Site Initiation Practices
As the SCOPE Summit approaches next week, it's clear sponsors and CROs still face many…
